Abstract Current therapies for inflammatory bowel disease (IBD), such as olsalazine and cyclosporine, often exhibit limited long-term efficacy and are…
Abstract Aims: Since 2016, more than one million new patients with chronic health conditions have been prescribed medicinal cannabis in…
Abstract Background: Inflammatory bowel disease (IBD) is a chronic inflammatory disorder marked by persistent gastrointestinal inflammation and a spectrum of…
Abstract Industrial hemp biomass, the low Δ9-tetrahydrocannabinol variety of Cannabis sativa, has been identified as a potential feed for ruminants.…
Abstract Humans have employed cannabis for multiple uses including medicine, recreation, food, and fibre. The various components such as roots,…
Abstract Aims: Patients with chronic health conditions not responding to conventional treatment can access medicinal cannabis (MC) prescriptions from clinicians…